Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Non-Hodgkin Lymphoma (All Stages^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


Puerto Rico6


New Mexico7


District of Columbia6


Arizona6


Hawaii7


Alabama6


South Carolina6


Wyoming6


Mississippi6


Colorado6


Virginia6


Oklahoma6


Texas7


Tennessee6


Georgia7


North Carolina6


Delaware6


California7


Alaska6


Montana6


Maryland6


Oregon6


Utah7


Arkansas6


Missouri6


Vermont6


Louisiana7


Rhode Island6


Michigan6


North Dakota6


Kansas6


Massachusetts7


Illinois7


Washington5


Ohio6


Idaho7


Nebraska6


South Dakota6


West Virginia6


Kentucky7


Pennsylvania6


Maine6


Connecticut7


Wisconsin6


New Hampshire6


New York7


Iowa7


New Jersey7


Florida6


Minnesota6


Indiana6 Nevada6

Notes:
Created by statecancerprofiles.cancer.gov on 02/24/2024 12:37 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.